383 related articles for article (PubMed ID: 24947527)
1. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
2. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
4. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ
Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376
[TBL] [Abstract][Full Text] [Related]
5. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.
Escolà-Gil JC; Julve J; Llaverias G; Urpi-Sarda M; Silvennoinen R; Lee-Rueckert M; Andres-Lacueva C; Blanco-Vaca F
Transl Res; 2013 Feb; 161(2):110-7. PubMed ID: 23146569
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
[TBL] [Abstract][Full Text] [Related]
8. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
9. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models.
Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC
Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699
[TBL] [Abstract][Full Text] [Related]
10. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
Ma AZ; Song ZY; Zhang Q
BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
[TBL] [Abstract][Full Text] [Related]
13. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
[TBL] [Abstract][Full Text] [Related]
14. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis.
Lo Sasso G; Murzilli S; Salvatore L; D'Errico I; Petruzzelli M; Conca P; Jiang ZY; Calabresi L; Parini P; Moschetta A
Cell Metab; 2010 Aug; 12(2):187-93. PubMed ID: 20674863
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
18. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
[TBL] [Abstract][Full Text] [Related]
19. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
[TBL] [Abstract][Full Text] [Related]
20. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]